IHH Healthcare Berhad Future Growth

Future criteria checks 0/6

IHH Healthcare Berhad's earnings are forecast to decline at 0.3% per annum while its annual revenue is expected to grow at 6% per year. EPS is expected to decline by 1% per annum. Return on equity is forecast to be 6.7% in 3 years.

Key information

-0.3%

Earnings growth rate

-1.0%

EPS growth rate

Healthcare earnings growth1.3%
Revenue growth rate6.0%
Future return on equity6.7%
Analyst coverage

Good

Last updated10 Jul 2024

Recent future growth updates

No updates

Recent updates

Returns On Capital Are Showing Encouraging Signs At IHH Healthcare Berhad (KLSE:IHH)

Jul 16
Returns On Capital Are Showing Encouraging Signs At IHH Healthcare Berhad (KLSE:IHH)

IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 29% Below Their Intrinsic Value Estimate

Jun 24
IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 29% Below Their Intrinsic Value Estimate

Some Investors May Be Willing To Look Past IHH Healthcare Berhad's (KLSE:IHH) Soft Earnings

Jun 05
Some Investors May Be Willing To Look Past IHH Healthcare Berhad's (KLSE:IHH) Soft Earnings

Do IHH Healthcare Berhad's (KLSE:IHH) Earnings Warrant Your Attention?

May 28
Do IHH Healthcare Berhad's (KLSE:IHH) Earnings Warrant Your Attention?

Unpleasant Surprises Could Be In Store For IHH Healthcare Berhad's (KLSE:IHH) Shares

May 13
Unpleasant Surprises Could Be In Store For IHH Healthcare Berhad's (KLSE:IHH) Shares

IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly

Mar 17
IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly

Does IHH Healthcare Berhad (KLSE:IHH) Deserve A Spot On Your Watchlist?

Feb 25
Does IHH Healthcare Berhad (KLSE:IHH) Deserve A Spot On Your Watchlist?

Investors Will Want IHH Healthcare Berhad's (KLSE:IHH) Growth In ROCE To Persist

Feb 09
Investors Will Want IHH Healthcare Berhad's (KLSE:IHH) Growth In ROCE To Persist

Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

Jan 25
Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

Subdued Growth No Barrier To IHH Healthcare Berhad's (KLSE:IHH) Price

Jan 09
Subdued Growth No Barrier To IHH Healthcare Berhad's (KLSE:IHH) Price

Is IHH Healthcare Berhad (KLSE:IHH) A Risky Investment?

Nov 27
Is IHH Healthcare Berhad (KLSE:IHH) A Risky Investment?

There's Been No Shortage Of Growth Recently For IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital

Oct 25
There's Been No Shortage Of Growth Recently For IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital

Is Now The Time To Put IHH Healthcare Berhad (KLSE:IHH) On Your Watchlist?

Oct 10
Is Now The Time To Put IHH Healthcare Berhad (KLSE:IHH) On Your Watchlist?

Estimating The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)

Sep 14
Estimating The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)

Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up

Jul 24
Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up

Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors

Jun 16
Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors

IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 22% Above Their Intrinsic Value Estimate

May 18
IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 22% Above Their Intrinsic Value Estimate

IHH Healthcare Berhad (KLSE:IHH) Has A Pretty Healthy Balance Sheet

Apr 26
IHH Healthcare Berhad (KLSE:IHH) Has A Pretty Healthy Balance Sheet

IHH Healthcare Berhad (KLSE:IHH) Has Announced That It Will Be Increasing Its Dividend To MYR0.07

Mar 16
IHH Healthcare Berhad (KLSE:IHH) Has Announced That It Will Be Increasing Its Dividend To MYR0.07

Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up

Mar 10
Returns At IHH Healthcare Berhad (KLSE:IHH) Are On The Way Up

Calculating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

Feb 17
Calculating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

These 4 Measures Indicate That IHH Healthcare Berhad (KLSE:IHH) Is Using Debt Reasonably Well

Jan 25
These 4 Measures Indicate That IHH Healthcare Berhad (KLSE:IHH) Is Using Debt Reasonably Well

IHH Healthcare Berhad (KLSE:IHH) Shareholders Will Want The ROCE Trajectory To Continue

Nov 23
IHH Healthcare Berhad (KLSE:IHH) Shareholders Will Want The ROCE Trajectory To Continue

A Look At The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)

Nov 04
A Look At The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)

IHH Healthcare Berhad (KLSE:IHH) Has A Rock Solid Balance Sheet

Oct 18
IHH Healthcare Berhad (KLSE:IHH) Has A Rock Solid Balance Sheet

Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors

Oct 02
Here's Why IHH Healthcare Berhad (KLSE:IHH) Has Caught The Eye Of Investors

IHH Healthcare Berhad (KLSE:IHH) Is Experiencing Growth In Returns On Capital

Aug 23
IHH Healthcare Berhad (KLSE:IHH) Is Experiencing Growth In Returns On Capital

Is IHH Healthcare Berhad (KLSE:IHH) Trading At A 27% Discount?

Jul 22
Is IHH Healthcare Berhad (KLSE:IHH) Trading At A 27% Discount?

Does IHH Healthcare Berhad (KLSE:IHH) Have A Healthy Balance Sheet?

Jul 07
Does IHH Healthcare Berhad (KLSE:IHH) Have A Healthy Balance Sheet?

With EPS Growth And More, IHH Healthcare Berhad (KLSE:IHH) Makes An Interesting Case

Jun 22
With EPS Growth And More, IHH Healthcare Berhad (KLSE:IHH) Makes An Interesting Case

Getting In Cheap On IHH Healthcare Berhad (KLSE:IHH) Is Unlikely

Jun 06
Getting In Cheap On IHH Healthcare Berhad (KLSE:IHH) Is Unlikely

The Return Trends At IHH Healthcare Berhad (KLSE:IHH) Look Promising

May 23
The Return Trends At IHH Healthcare Berhad (KLSE:IHH) Look Promising

Is There An Opportunity With IHH Healthcare Berhad's (KLSE:IHH) 21% Undervaluation?

Apr 18
Is There An Opportunity With IHH Healthcare Berhad's (KLSE:IHH) 21% Undervaluation?

Earnings and Revenue Growth Forecasts

KLSE:IHH - Analysts future estimates and past financials data (MYR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202625,5362,2623,3514,80916
12/31/202524,0162,0292,4514,33520
12/31/202422,4611,8842,1424,42620
3/31/202421,7482,3291,5813,930N/A
12/31/202320,9352,9521,8163,759N/A
9/30/202321,5252,4161,8693,747N/A
6/30/202320,2802,1281,8463,432N/A
3/31/202318,9682,4152,1943,864N/A
12/31/202217,9891,4961,9513,668N/A
9/30/202217,9671,7362,2733,945N/A
6/30/202217,7362,0192,3363,775N/A
3/31/202217,4351,8912,2723,429N/A
12/31/202117,2181,7742,4773,532N/A
9/30/202116,4271,7402,2493,169N/A
6/30/202115,5001,5002,2953,168N/A
3/31/202113,7958951,7502,549N/A
12/31/202013,4051991,5532,445N/A
9/30/202013,475-1801,4182,402N/A
6/30/202013,745-2531,1102,093N/A
3/31/202014,825531,3532,488N/A
12/31/201914,9124631,3692,447N/A
9/30/201914,2429321,3072,265N/A
6/30/201913,2945929481,995N/A
3/31/201912,3095737811,857N/A
12/31/201811,5215428031,864N/A
9/30/201811,2411348362,065N/A
6/30/201811,2013261,2102,295N/A
3/31/201811,3134981,0942,258N/A
12/31/201711,143931N/A2,261N/A
9/30/201710,889810N/A2,186N/A
6/30/201710,530917N/A1,984N/A
3/31/201710,231847N/A1,983N/A
12/31/201610,022612N/A1,934N/A
9/30/20169,6851,071N/A1,875N/A
6/30/20169,3081,016N/A1,884N/A
3/31/20168,928998N/A1,917N/A
12/31/20158,455934N/A1,986N/A
9/30/20158,098757N/A1,836N/A
6/30/20157,818786N/A1,858N/A
3/31/20157,589767N/A1,771N/A
12/31/20147,344754N/A1,631N/A
9/30/20147,187745N/A1,656N/A
6/30/20147,075715N/A1,537N/A
3/31/20146,889663N/A1,382N/A
12/31/20136,756631N/A1,338N/A
9/30/20136,504558N/A1,025N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IHH's earnings are forecast to decline over the next 3 years (-0.3% per year).

Earnings vs Market: IHH's earnings are forecast to decline over the next 3 years (-0.3% per year).

High Growth Earnings: IHH's earnings are forecast to decline over the next 3 years.

Revenue vs Market: IHH's revenue (6% per year) is forecast to grow slower than the MY market (6.3% per year).

High Growth Revenue: IHH's revenue (6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IHH's Return on Equity is forecast to be low in 3 years time (6.7%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.